Method of forming and using deactivation wipe kit

US2022017843A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2022017843-A1
Application numberUS-202117402750-A
CountryUS
Kind codeA1
Filing dateAug 16, 2021
Priority dateApr 11, 2016
Publication dateJan 20, 2022
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A hazardous drug deactivation wipe kit includes a first pouch having a one-way valve coupled to an end thereof, a second pouch, and a third pouch. The first pouch contains a wipe saturated in a hypochlorite solution, the second pouch contains a wipe saturated in thiosulfate solution, and the third pouch contains a wipe saturated in isopropyl alcohol solution. The deactivation wipe kit may be used in a clean room to deactivate most hazardous drugs on a work surface.

First claim

Opening claim text (preview).

1 - 27 . (canceled) 28 . A clean room wipe kit, comprising: a first flexible pouch containing at least one first wipe saturated in first solution, the first solution being configured to deactivate hazardous drugs; a second flexible pouch containing at least one second wipe saturated in a second solution, the second solution being configured to clean, decontaminate, and neutralize the first solution; and a third flexible pouch containing at least one third wipe saturated in a third solution, the third solution being a disinfectant, wherein the clean room wipe kit is configured for use in a controlled environment to deactivate hazardous drugs on a work surface by using the first, second, and third wipes of the first, second, and third flexible pouches, respectively, in sequence. 29 . The clean room wipe kit of claim 28 , wherein each of the first, second, and third flexible pouch is configured for irradiation sterilization. 30 . The clean room wipe kit of claim 28 , wherein each of the first, second, and third flexible pouch is hermetically sealed. 31 . The clean room wipe kit of claim 28 , wherein the first flexible pouch includes a one-way filling valve that is configured to permit the first solution to be filled into the first pouch while preventing the first solution from escaping the first pouch. 32 . The clean room wipe kit of claim 31 , wherein the one-way filling valve is configured to permit the first pouch to be filled with the first solution after the first wipe has already been sealed in the first pouch. 33 . The clean room wipe kit of claim 28 , wherein the first, second, and third solutions are chemicals that are different from one another. 34 . The clean room wipe kit of claim 28 , wherein the first solution is a hypochlorite solution, the second solution is a thiosulfate solution, and the third solution is an isopropyl alcohol solution. 35 . The clean room wipe kit of claim 34 , wherein the hypochlorite solution is a 5.25% sodium hypochlorite solution. 36 . The clean room wipe kit of claim 34 , wherein the thiosulfate solution is a 2% sodium thiosulfate solution. 37 . The clean room wipe kit of claim 34 , wherein the isopropyl alcohol solution is a 70% isopropyl alcohol solution. 38 . The clean room wipe kit of claim 28 , wherein the first wipe in the first flexible pouch is formed of polypropylene, and the second wipe in the second flexible pouch and the third wipe in the third flexible pouch are formed of polyester. 39 . The clean room wipe kit of claim 28 , wherein each of the first flexible pouch, the second flexible pouch, and the third flexible pouch comprises a perforation adjacent to an end thereof. 40 . The clean room wipe kit of claim 28 , further comprising one or more plastic bags in which the first, second, and third flexible pouches can be hermetically sealed. 41 . The clean room wipe kit of claim 28 , wherein each of the first, second, and third flexible pouches has indicia indicating the use of the first, second, and third wipes in sequence. 42 . The clean room wipe kit of claim 41 , wherein the indicia on the first flexible pouch is the number one, the indicia on the second flexible pouch is the number two, and the indicia on the third flexible pouch is the number three. 43 . A clean room wipe kit, comprising: a first sealed pouch having a one-way filling valve coupled to an end thereof, the first pouch containing a wipe saturated in first solution, wherein the one-way filling valve is configured to permit the first solution to be filled into the first pouch while preventing the first solution to escape the first pouch; and a second sealed pouch containing a wipe saturated in second solution, wherein the first solution is configured to deactivate hazardous drugs and the second solution is configured to clean, decontaminate, and neutralize the first solution. 44 . The clean room wipe kit of claim 43 , wherein the first solution is a hypochlorite solution and the second solution is a thiosulfate solution. 45 . The clean room wipe kit of claim 43 , wherein the kit is configured for use in a controlled environment to deactivate hazardous drugs on a work surface by using the wipe of the first sealed pouch first and then using the wipe of the second sealed wipe second. 46 . The clean room wipe kit of claim 43 , wherein each of the first and second sealed pouches has indicia indicating the use of the wipes of the first and second sealed pouches, respectively, in sequence. 47 . The clean room wipe kit of claim 46 , wherein the indicia on the first sealed pouch is the number one and the indicia on the second sealed pouch is the number two.

Assignees

Inventors

Classifications

  • C11D17/049Primary

    Cleaning or scouring pads; Wipes · CPC title

  • Alcohols; Phenols · CPC title

  • Salts · CPC title

  • for tearing a side strip parallel and next to the edge, e.g. by means of a line of weakness · CPC title

  • Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2022017843A1 cover?
A hazardous drug deactivation wipe kit includes a first pouch having a one-way valve coupled to an end thereof, a second pouch, and a third pouch. The first pouch contains a wipe saturated in a hypochlorite solution, the second pouch contains a wipe saturated in thiosulfate solution, and the third pouch contains a wipe saturated in isopropyl alcohol solution. The deactivation wipe kit may be us…
Who is the assignee on this patent?
Veltek Ass Inc
What technology area does this patent fall under?
Primary CPC classification C11D17/049. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Jan 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).